CCM
ZY

CAAS Capital Management’s Zymergen Inc. Common Stock ZY Stock Holding History

CAAS Capital Management’s Portfolio ZY Stock Details ZY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-45,180
Closed -$595K – 1144
2021
Q3 		$595K Sell
45,180
-54,820
-55% -$1.16M 0.01% 586
2021
Q2 		$4M Buy
+100,000
New +$3.95M 0.07% 280

Other funds holding ZY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
TVPI
True Venture Partners IV Palo Alto, California $8.41M AUM 78.89% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
DCI
Data Collective II Palo Alto, California $8.44M AUM 11.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TSV
Two Sigma Ventures New York $9.61M AUM 58.41% 1-Year Est. Return

CAAS Capital Management's ZY Position: Q4 2021 in Review

CAAS Capital Management sold out of Zymergen Inc. Common Stock (ZY) in Q4 2021, closing a stake of 45,180 shares — an estimated $595K sold.

CAAS Capital Management first reported a position in ZY in Q2 2021 and held it in 2 quarters. The position peaked at $4M in Q2 2021. 91 funds tracked by Wall St. Rank hold ZY as of Q4 2021.

  • CAAS Capital Management reported no remaining Zymergen Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • CAAS Capital Management sold 45,180 Zymergen Inc. Common Stock shares in Q4 2021, an estimated $595K.
  • CAAS Capital Management first reported a position in Zymergen Inc. Common Stock in Q2 2021 and held it in 2 quarters.
  • CAAS Capital Management's Zymergen Inc. Common Stock position peaked at $4M in Q2 2021.
  • 91 funds tracked by Wall St. Rank held Zymergen Inc. Common Stock as of Q4 2021.

Based on CAAS Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.